Refractory/Relapsed Chronic Lymphocytic Leukemia

1 clinical trials · Condition

Record	Firm	Date
PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia (NCT01589302)	Kami Maddocks, MD	2012-05-21

Every clearance here is in the API, with alerts when new ones post.